JLM-BioCity is a non-profit organization focused on developing Jerusalem’s bio-community

Activities include: ♦ Networking platform ♦ Fund raising opportunities ♦ Investing in the bio-community students, professionals and executives ♦ Expanding and maintaining the bio-eco-system-entrepreneurs-startups-companies-academia-hospitals ♦ Creating local and international B2B collaborations ♦

Event Videos

Play

With Added $25M+ Financing, Nectin Therapeutics Initiates Patient Dosing in Advanced Solid Tumors NTX1088 Phase 1 Trial

December 1, 2022

Myeloma Investment Fund Invests in KAHR’s Lead Immunotherapy Drug for Multiple Myeloma Treatment

November 28, 2022

Alpha Tau and MIM Software Are Collaborating On Alpha DaRT Treatment Planning

November 6, 2022

Visit Image Navigation’s Latest Dental Surgical Navigational Systems at MIXiii BioConference in Jerusalem, Nov 9-10, 2022

November 6, 2022

Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine

October 31, 2022

Positive Preliminary Phase 1 Data for Oramed Subsidiary Oravax’s Oral Covid-19 Vaccine

October 13, 2022

BioTips

Brexit Image for Tip #12 Why Brexit Affects Israeli Companies

Tip: Why Brexit Affects Israeli Companies

June 10, 2021

audit images for Tip #11: What are Audited Financial Statements and Auditor’s Opinions

Tip: What are Audited Financial Statements and Auditor’s Opinions

April 30, 2021

Tip: What is a Cap Table

April 28, 2021

More JLM-BioCity events coming soon…

Because every biotech and medtech professional knows that Jerusalem BioCity consistently delivers world-class programming, the best professionals always show up and the networking before and after the events is worth its time in gold.

- Moshe Lebowitz, CEO, Healables Digital Health | Healables: Wearables that Heal

The JLM Biocity networking events on Zoom keeps getting better. For OmnySense they have provided an excellent forum in which to present our company, and the break-out sessions facilitate direct discussion with a broad range of potential partners and investors.

- Ian Solomon CTO, OmnySense Ltd.

JLM-BioCity's events are well organized with a professional approach. You can feel a "homey" atmosphere around the people of a well-maintained bio-community in Jerusalem. Team members always make sure the guests feel welcome and connected to the right people for possible collaborations. There are clearly visible good-will and dedication to lead the members of the bio-community and the city as a whole to success.

- Dror Chevion CEO, Concenter BioPharma

I believe in the idea of JLM-BioCity. It is good that there is an organization that represents the life science companies in Jerusalem and provides an excellent platform for networking through its regular meetings.

- Immanuel Lerner CEO, Pepticom

Excellent event. Good speakers, interesting audience. Well done!

- Gideon Silberman, Director of Business Development, Partner and Co-Founder, Aneeva.com

Thank you all for the great evening, it was a pleasure to see such a good and diverse set of Biomed minded people in Jerusalem!

- Zeev Malyutin, Protein Department Head, Merck KGaA

Such an interesting lecture and great people attending!

- Aurélie Schwarzbach, Clinical Project Manager, Gamida Cell Ltd.

Interesting - I could see it helping people network - a good thing!

- Jonathan Miller, Founder, President, and Designer, U-Step, Neurological Walking Aids

Great atmosphere, great people.

- Yael Ophir, Executive Director, HealthIL

There was an excellent networking atmosphere with impressive Panelists as well as high-quality audience participants. I strongly recommend paying attention to future events.

Aviv Marom, Director, Strategic Partnerships, Samsung Research, Israel

Very informative and eye-opening event. Thank you for the great hospitality.

- Hemda Idel, founder, SLEEP ASAP

one of the best meetups organizations and a very important source of information and connections for startups.

Tal Or, Co-Founder, ATLASense Biomed Ltd.

Excellent organization (from the timing to food), the quality of the audience was superior, we personally got a lot of hot leads.

Alexander Naslednikov, Founder and CEO, Med.me

<< Prev

Next >>

JLM-BioCity was recently written up in THE MARKER (in Hebrew). To see the article, click here.

JLM-BioCity is a non-profit organization focused on developing Jerusalem’s bio-community

Event Videos

JLM NEWS | Bi0 Innovation

With Added $25M+ Financing, Nectin Therapeutics Initiates Patient Dosing in Advanced Solid Tumors NTX1088 Phase 1 Trial

Myeloma Investment Fund Invests in KAHR’s Lead Immunotherapy Drug for Multiple Myeloma Treatment

Alpha Tau and MIM Software Are Collaborating On Alpha DaRT Treatment Planning

Visit Image Navigation’s Latest Dental Surgical Navigational Systems at MIXiii BioConference in Jerusalem, Nov 9-10, 2022

Immunyx Pharma Part of Global Consortium CanceRNA Developing RNA-based Cancer Vaccine

Positive Preliminary Phase 1 Data for Oramed Subsidiary Oravax’s Oral Covid-19 Vaccine

BioTips

Tip: Why Brexit Affects Israeli Companies

Tip: What are Audited Financial Statements and Auditor’s Opinions

Tip: What is a Cap Table

Strategic Partners

Platinum

Gold

Silver

Contact us at

Follow us

Copyright © 2020 JLM-BioCity | All rights reserved